C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2005
01/04/2005	US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
01/04/2005	US6838557 Process for making a chelating agent for labeling biomolecules using preformed active esters
01/04/2005	US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
01/04/2005	US6838479 Amidine inhibitors of serine proteases
01/04/2005	US6838464 Inhibitor of cyclin-dependent kinase
01/04/2005	US6838461 Psychological disorders; schizophrenia; Alzheimer's disease; Parkinson's disease; Huntington's disease; cardiovascular disorders; hypotensive agents; side effect reduction
01/04/2005	US6838455 Inhibiting beta -amyloid peptide release and/or its synthesis in a cell by administering deoxyamino acid compound
01/04/2005	US6838453 Therapy for osteoporosis
01/04/2005	CA2340999C 5-arylindole derivatives
01/04/2005	CA2124696C Vasopressin antagonist and oxytocin antagonist
12/2004
12/30/2004	US20040267020 Process for production cilostazol
12/30/2004	US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
12/30/2004	US20040267014 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them
12/30/2004	US20040266855 Effective against Src family; cancer, osteoporosis
12/30/2004	US20040266854 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
12/30/2004	US20040266800 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors
12/30/2004	US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta
12/30/2004	US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases
12/30/2004	US20040266774 Amide compounds
12/30/2004	US20040266763 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
12/30/2004	US20040266762 Indole derivatives having an apoptosis-inducing effect
12/30/2004	US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine
12/30/2004	US20040266750 Beta-lactamyl vasopressin v1aantagonists
12/30/2004	US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
12/30/2004	US20040261190 Hydrazono-malonitriles
12/30/2004	DE10326386A1 N-Heterocyclyl-phenylsubstituierte cyclische Ketoenole N-heterocyclyl-substituted cyclic ketoenols
12/29/2004	WO2004113324A1 Chinazoline derivatives as aurora kinase inhibitors
12/29/2004	WO2004113290A1 Substituted alkylamides
12/29/2004	WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/29/2004	WO2004112719A2 Chemical compounds
12/29/2004	WO2004112709A2 Inhibitors of cathepsin s
12/29/2004	WO2004101767A3 Cbi analogues of the duocarmycins and cc-1065
12/29/2004	WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors
12/29/2004	WO2003099793A8 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/29/2004	EP1491541A1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1491540A1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1491534A1 Novel hairpin polyamide
12/29/2004	EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors
12/29/2004	EP1491206A1 Induction method for cell differentiation
12/29/2004	EP1490355A1 Indolylmaleimide derivatives
12/29/2004	EP1490354A1 4-imidazolyl substituted pyrimidine derivatives with cdk inhibitory activity
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490058A1 Peroxisome proliferator activated receptor modulators
12/29/2004	EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
12/29/2004	EP1490055A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
12/29/2004	EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1282612B1 Alkynyl phenyl heteroaromatic glucokinase activators
12/29/2004	EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines
12/29/2004	EP1226138B1 Fab i inhibitors
12/29/2004	EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	CN1558906A Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
12/29/2004	CN1558904A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558897A Antidiabetic agents
12/29/2004	CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer
12/29/2004	CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1557955A Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/29/2004	CA2529949A1 Antiviral compounds and methods
12/29/2004	CA2529250A1 Chinazoline derivatives as aurora kinase inhibitors
12/29/2004	CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/28/2004	US6835744 3,3-substituted indoline derivatives
12/28/2004	US6835741 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/28/2004	US6835729 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/28/2004	US6835726 For therapy of viral infections, particularly human Cytomegalovirus infection
12/28/2004	US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier
12/28/2004	US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors
12/28/2004	US6835513 An organophotoreceptor comprising: (a) a charge transport compound having the formula carbazole compound dispersion of colorant particles in an organic liquid and charge transport compound having the formula of carbazole compound
12/28/2004	US6835329 Photostability; hindered amine light stabilizers
12/23/2004	WO2004111042A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
12/23/2004	WO2004111041A1 Pyrrolidine, thiazolidine and oxazolidine compounds which inhibit dipeptidyl peptidase-iv (dpp)
12/23/2004	WO2004111040A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
12/23/2004	WO2004111034A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004111009A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	WO2004110999A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	WO2004110997A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa
12/23/2004	WO2004110996A1 Nk1 antagonist
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004110452A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	WO2004110436A1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/23/2004	WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
12/23/2004	WO2004110344A2 New azetidine compounds
12/23/2004	WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004085392A8 Melatonin derivatives and their use for treating neurological dysfunctions
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004071447A3 Substituted azole derivatives as therapeutic agents
12/23/2004	WO2004071390A3 Piperazine-2-carboxamide derivatives
12/23/2004	US20040259929 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment

1 ... 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 ... 626